Medical Weight Loss for Central, Louisiana Residents
Central, Louisiana residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Central through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Central Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Central, Louisiana residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Central is served by telemedicine from our Costa Mesa, California clinic. The same physician-supervised semaglutide and tirzepatide programs are available by secure video, with medication shipped to your door.
Central is served entirely by telehealth, so there is no local office to visit and no waiting room. We care for patients throughout Central and the greater East Baton Rouge Parish area. There is no distance surcharge for Central patients, and HSA, FSA, Klarna, and Affirm are all accepted.
Our telehealth model serves Central and communities across Louisiana with the same flat pricing and the same supervising physician. The first step is a $119 physician review; if you are not a candidate you are not charged, and compounded semaglutide starts at $166/month.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Central
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month · just $7.70/day and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Central
Step 1: Complete the 2-minute quiz or the medical intake form online.
Step 2: Dr. Sharma reviews your history by secure video, typically within 48 hours.
Step 3: If you are a candidate and telehealth-eligible, the state-licensed 503(a) pharmacy ships your compounded medication to your Central address in cold-pack packaging. Follow-ups and dose adjustments also happen by video, no travel required.
Frequently Asked Questions, Central
How do I get treatment from Central?
As a Central, Louisiana patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Central?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Central in cold-pack packaging, no lines and no drive.
How much does it cost for Central patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Central do you serve?
We serve patients from across Central by telehealth, including Central and the greater East Baton Rouge Parish area.
How does compounded medication compare on cost for Central patients?
Compounded semaglutide from $166/month and tirzepatide from $233/month are a fraction of typical brand-name cash prices. Central patients see flat pricing up front, and compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Central, Louisiana by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.